Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Blood and urine markers for ovarian cancer: a comprehensive review.

Literature DB >> 15322314

Blood and urine markers for ovarian cancer: a comprehensive review.

Kathryn L Terry¹, Patrick M Sluss, Steven J Skates, Samuel C Mok, Bin Ye, Allison F Vitonis, Daniel W Cramer.

Abstract

Entities: Disease

Mesh：

Substances：
Biomarkers, Tumor

Year: 2004 PMID： 15322314 PMCID： PMC3839278 DOI： 10.1155/2004/241982

Source DB: PubMed Journal: Dis Markers ISSN： 0278-0240 Impact factor: 3.434

× No keyword cloud information.

18 in total

1. Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response.

Authors: Yu-Li Chen; Ming-Cheng Chang; Chia-Yen Huang; Ying-Cheng Chiang; Han-Wei Lin; Chi-An Chen; Chang-Yao Hsieh; Wen-Fang Cheng
Journal: Mol Oncol Date: 2011-12-20 Impact factor: 6.603

2. A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.

Authors: Hsin-Yao Tang; Lynn A Beer; Tony Chang-Wong; Rachel Hammond; Phyllis Gimotty; George Coukos; David W Speicher
Journal: J Proteome Res Date: 2011-11-18 Impact factor: 4.466

3. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.

Authors: Karen S Anderson; Jessica Wong; Allison Vitonis; Christopher P Crum; Patrick M Sluss; Joshua Labaer; Daniel Cramer
Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-03-03 Impact factor: 4.254

4. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

Authors: Daniel W Cramer; Robert C Bast; Christine D Berg; Eleftherios P Diamandis; Andrew K Godwin; Patricia Hartge; Anna E Lokshin; Karen H Lu; Martin W McIntosh; Gil Mor; Christos Patriotis; Paul F Pinsky; Mark D Thornquist; Nathalie Scholler; Steven J Skates; Patrick M Sluss; Sudhir Srivastava; David C Ward; Zhen Zhang; Claire S Zhu; Nicole Urban
Journal: Cancer Prev Res (Phila) Date: 2011-03

5. Challenges related to developing serum-based biomarkers for early ovarian cancer detection.

Authors: Phuong L Mai; Nicolas Wentzensen; Mark H Greene
Journal: Cancer Prev Res (Phila) Date: 2011-03

6. A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.

Authors: Kathryn L Terry; Helena Schock; Renée T Fortner; Anika Hüsing; Raina N Fichorova; Hidemi S Yamamoto; Allison F Vitonis; Theron Johnson; Kim Overvad; Anne Tjønneland; Marie-Christine Boutron-Ruault; Sylvie Mesrine; Gianluca Severi; Laure Dossus; Sabina Rinaldi; Heiner Boeing; Vassiliki Benetou; Pagona Lagiou; Antonia Trichopoulou; Vittorio Krogh; Elisabetta Kuhn; Salvatore Panico; H Bas Bueno-de-Mesquita; N Charlotte Onland-Moret; Petra H Peeters; Inger Torhild Gram; Elisabete Weiderpass; Eric J Duell; Maria-Jose Sanchez; Eva Ardanaz; Nerea Etxezarreta; Carmen Navarro; Annika Idahl; Eva Lundin; Karin Jirström; Jonas Manjer; Nicholas J Wareham; Kay-Tee Khaw; Karl Smith Byrne; Ruth C Travis; Marc J Gunter; Melissa A Merritt; Elio Riboli; Daniel W Cramer; Rudolf Kaaks
Journal: Clin Cancer Res Date: 2016-04-08 Impact factor: 12.531

7. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.

Authors: Elena Kupert; Marshall Anderson; Yin Liu; Paul Succop; Linda Levin; Jiang Wang; Kathryn Wikenheiser-brokamp; Pingping Chen; Susan M Pinney; Trudy Macdonald; Zhongyun Dong; Sandra Starnes; Shan Lu
Journal: BMC Cancer Date: 2011-12-09 Impact factor: 4.430